Mobocertinib (TAK-788) in metastatic EGFR Exon 20 Insertions (ex20ins) + NSCLC: Results of platinum-experienced Patients and the EXCLAIM Cohort of a Phase 1/2 Study Meeting Abstract

International Collaboration

cited authors

  • Misch, D.; Ramalingam, S.; Zhou, C.; Kim, T. M.; Yang, J. C.; Riely, G.; Mekhail, T.; Nguyen, D.; Campelo, Garcia M. R.; Felip, E.; Bunn, V.; Lin, H.; Zhang, P.; Jaenne, P.; Kaur, M.

authors

Publication Date

  • September 1, 2022

webpage

published in

category

start page

  • 96

end page

  • 97

volume

  • 45

issue

  • SUPPL 2